STK39, a Ser/Thr kinase, has been reported to participate in the progression of multiple human cancers, such as osteosarcoma, renal cell carcinoma and non-small cell type lung cancer cells [8,9,16]. This evidence concerns the gene STK39 and osteosarcoma.